Sandhoff disease is a variation of the rare and usually fatal genetic disorder Tay-Sachs disease, which causes progressive damage to the nervous system. Professor Timothy Cox's research group is working to develop gene therapy for children who have inherited Sandhoff disease.
Next steps
In the most common form of Tay-Sachs condition, symptoms usually begin at around six months of age, when a previously normal child's development begins to slow and they gradually lose their ability to move. Mainly it is in Sandhoff disease models that gene therapy programmes and other enhancing treatments have been first tried; babies have responded well to gene therapy, which is being extended to Tay-Sachs disease sufferers too.
Next steps
You can support Sandhoff disease research at Cambridge by donating online, leaving a legacy in your Will, or to discuss your philanthropic goals, please contact:
Make a gift now
Make a gift now to support by credit or debit card, or set up a direct debit:
Give nowOr, find out about other ways to give.
Associate Director, Cambridge University Health Partners
- Harriet Aspin
- harriet.aspin@admin.cam.ac.uk
